| pubmed-article:12147788 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12147788 | lifeskim:mentions | umls-concept:C0011881 | lld:lifeskim |
| pubmed-article:12147788 | lifeskim:mentions | umls-concept:C0126174 | lld:lifeskim |
| pubmed-article:12147788 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:12147788 | lifeskim:mentions | umls-concept:C2698651 | lld:lifeskim |
| pubmed-article:12147788 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:12147788 | pubmed:dateCreated | 2002-7-30 | lld:pubmed |
| pubmed-article:12147788 | pubmed:abstractText | Angiotensin II subtype-1 receptor antagonists represent a valuable new class of drugs in the treatment of diabetic nephropathy. The aim of our study was to evaluate the optimal dose of losartan for renoprotection and blood pressure reduction in diabetic nephropathy. | lld:pubmed |
| pubmed-article:12147788 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12147788 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12147788 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12147788 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12147788 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12147788 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12147788 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:12147788 | pubmed:issn | 0931-0509 | lld:pubmed |
| pubmed-article:12147788 | pubmed:author | pubmed-author:ParvingHans-H... | lld:pubmed |
| pubmed-article:12147788 | pubmed:author | pubmed-author:AndersenSteen... | lld:pubmed |
| pubmed-article:12147788 | pubmed:author | pubmed-author:DeinumJaapJ | lld:pubmed |
| pubmed-article:12147788 | pubmed:author | pubmed-author:RossingPeterP | lld:pubmed |
| pubmed-article:12147788 | pubmed:author | pubmed-author:JuhlTina RTR | lld:pubmed |
| pubmed-article:12147788 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12147788 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:12147788 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12147788 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12147788 | pubmed:pagination | 1413-8 | lld:pubmed |
| pubmed-article:12147788 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12147788 | pubmed:meshHeading | pubmed-meshheading:12147788... | lld:pubmed |
| pubmed-article:12147788 | pubmed:meshHeading | pubmed-meshheading:12147788... | lld:pubmed |
| pubmed-article:12147788 | pubmed:meshHeading | pubmed-meshheading:12147788... | lld:pubmed |
| pubmed-article:12147788 | pubmed:meshHeading | pubmed-meshheading:12147788... | lld:pubmed |
| pubmed-article:12147788 | pubmed:meshHeading | pubmed-meshheading:12147788... | lld:pubmed |
| pubmed-article:12147788 | pubmed:meshHeading | pubmed-meshheading:12147788... | lld:pubmed |
| pubmed-article:12147788 | pubmed:meshHeading | pubmed-meshheading:12147788... | lld:pubmed |
| pubmed-article:12147788 | pubmed:meshHeading | pubmed-meshheading:12147788... | lld:pubmed |
| pubmed-article:12147788 | pubmed:meshHeading | pubmed-meshheading:12147788... | lld:pubmed |
| pubmed-article:12147788 | pubmed:meshHeading | pubmed-meshheading:12147788... | lld:pubmed |
| pubmed-article:12147788 | pubmed:meshHeading | pubmed-meshheading:12147788... | lld:pubmed |
| pubmed-article:12147788 | pubmed:meshHeading | pubmed-meshheading:12147788... | lld:pubmed |
| pubmed-article:12147788 | pubmed:meshHeading | pubmed-meshheading:12147788... | lld:pubmed |
| pubmed-article:12147788 | pubmed:meshHeading | pubmed-meshheading:12147788... | lld:pubmed |
| pubmed-article:12147788 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12147788 | pubmed:articleTitle | Optimal dose of losartan for renoprotection in diabetic nephropathy. | lld:pubmed |
| pubmed-article:12147788 | pubmed:affiliation | Steno Diabetes Center, Copenhagen, Denmark. STAN@dadlnet.dk | lld:pubmed |
| pubmed-article:12147788 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12147788 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
